Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Paclitaxel and Cisplatin with Radiation for High-Risk Head and Neck Cancer
NCT00011999Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- Mar 2001
- Primary completion
- Feb 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by NRG Oncology. Primary endpoint: Patient tolerance of the treatment regimen. Started Mar 2001; status: completed.
02
Drugs
paclitaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00011999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00011999.